| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Calcium antagonistsClevidipineNorbormidePranidipineAH1058CilnidipineDiuretic agents (BASKET)AlcoholBeta adrenergic antagonistsCocainMethemoglobinemiaParacetamoleTheophyllineCyanideCO (Carbon monoxide)PesticidesBarbiturateOpioid (BASKET)LithiumGamma hydroxybutyric acidToxicology (BASKET)5 AminosalicylateOrganophosphorous compoundsAmphetaminesBenzodiazepinePhencyclidinessRI| 1 | 1996 | Short acting dihydropyridine (vasodilating) calcium channel blockers for hypertension: is there a risk? | 
| + | - | nl | BMJ 312(7039):1143-5 (1996) |
| 2 | 2001 | Epidemiologic review of the calcium channel blocker drugs. An up-to-date perspective on the proposed hazards. |
| + | - | nl | Arch Intern Med 161(9):1145-58 (2001) |
| 3 | 1997 | Calcium channel blockers: an evidence-based review. |
| + | - | nl | Can J Cardiol 13(8):757-66 (1997) |
| 4 | 2004 | Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control. |
| + | - | nl | Cardiovasc Drug Rev 22(3):227-50 (2004) |
| 5 | 2001 | Norbormide: a calcium entry blocker with selective vasoconstrictor activity in rat peripheral arteries. |
| + | - | nl | Cardiovasc Drug Rev 19(3):226-33 (2001) |
| 6 | 2001 | Pranidipine, a 1,4-dihydropyridine calcium channel blocker that enhances nitric oxide-induced vascular relaxation. |
| + | - | nl | Cardiovasc Drug Rev 19(1):1-8 (2001) |
| 7 | 2001 | AH-1058: a novel cardioselective Ca2+ channel blocker. |
| + | - | nl | Cardiovasc Drug Rev 19(4):279-96 (2001) |
| 8 | 2009 | Cilnidipine: a new generation Ca channel blocker with inhibitory action on sympathetic neurotransmitter release. |
| + | - | nl | Cardiovasc Ther 27(2):124-39 (2009) |
| 9 | 1986 | The mechanism of action of calcium antagonists relative to their clinical applications. |
| + | - | nl | Br J Clin Pharmacol 21 Suppl 2(-):109S-121S (1986) |
| 10 | 1986 | Calcium antagonists and their mode of action: an historical overview. |
| + | - | nl | Br J Clin Pharmacol 21 Suppl 2(-):97S-107S (1986) |
| 11 | 1992 | The diuretic effect of calcium entry blockade in normals and hypertensive patients. |
| + | - | nl | Tohoku J Exp Med 166(1):135-46 (1992) |
| 12 | 1992 | Molecular biology of the calcium antagonist receptor. |
| + | - | nl | Hypertension 19(1):19-24 (1992) |
| 13 | 1999 | Cardiovascular and renal risks of calcium-channel blockers--news from the HOT study. |
| + | - | nl | Nephrol Dial Transplant 14(2):286-7 (1999) |
| 14 | 1998 | Calcium channel blockers in diabetic nephropathy--is there life after the ABCD trial? |
| + | - | nl | Nephrol Dial Transplant 13(8):1930-2; discussion 1932-3 (1998) |
| 15 | 1997 | Preservation of renal function: the spectrum of effects by calcium-channel blockers. |
| + | - | nl | Nephrol Dial Transplant 12(11):2244-50 (1997) |
| 16 | 2003 | Adult toxicology in critical care: Part II: specific poisonings. | 
| + | - | nl | Chest 123(3):897-922 (2003) |
